Ordesekimab (Anti-IL-15)

Ordesekimab (Anti-IL-15) is a fully human monoclonal antibody targeting IL-15 and inhibiting the interaction of IL-15 with the IL-2Rβ. It has the potential for treatment of nonresponsive celiac disease (NRCD). MW :143.82 KD.
Supplier Selleck Chemicals
Product # A2451
Sku # A2451-1mg*5
Pricing 1mg*5, $490.00
Feedback